Market Outlook: Treatments and Trends in MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly classified as Non-Alcoholic Steatohepatitis (NASH), constitutes a severe manifestation of non-alcoholic fatty liver disease (NAFLD). This hepatic disorder is marked by liver inflammation combined with excessive fat deposition, commonly linked to metabolic abnormalities such as obesity, diabetes mellitus, and impaired insulin...
0 Comments 0 Shares